854 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Bronchogenic" (854 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
3 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
4 Recruiting International Ovarian & Testicular Stromal Tumor Registry
Conditions: Ovarian Stromal Tumor;   Testicular Stromal Tumors;   Ovarian Small Cell Carcinoma
Intervention:
5 Recruiting Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Conditions: Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: paclitaxel;   Drug: carboplatin;   Drug: erlotinib hydrochloride;   Drug: crizotinib;   Radiation: intensity-modulated radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Other: laboratory biomarker analysis
6 Unknown  A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
Conditions: Non-Small Cell Lung Cancer;   Solid Tumors
Intervention: Drug: Gefitinib and BKM120
7 Recruiting Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and GM-CSF in Treating Patients With Recurrent, Refractory, or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: EGFRBi-armed autologous activated T cells;   Biological: aldesleukin;   Biological: sargramostim
8 Not yet recruiting Erlotinib Intercalated With Chemotherapy Versus Erlotinib as First Line Treatment in Stage IIIB/IV NSCLC Patients With EGFR Mutation
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: gemcitabine; cisplatin or carboplatin; erlotinib;   Drug: erlotinib
9 Recruiting Pazopanib in Relapsed and Refractory Small Cell Lung Cancer
Condition: SCLC
Intervention: Drug: Pazopanib
10 Unknown  A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage
Condition: Small Cell Lung Cancer
Intervention: Drug: Carboplatin plus Irinotecan vs Carboplatin plus Etoposide
11 Recruiting Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care
Conditions: Adenocarcinoma of the Lung;   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Squamous Cell Lung Cancer;   Stage I Colon Cancer;   Stage I Rectal Cancer;   Stage IA Non-small Cell Lung Cancer;   Stage IB Non-small Cell Lung Cancer;   Stage IIA Colon Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIA Rectal Cancer;   Stage IIB Colon Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIB Rectal Cancer;   Stage IIC Colon Cancer;   Stage IIC Rectal Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Rectal Cancer
Interventions: Other: educational intervention;   Other: medical chart review
12 Recruiting Autologous Young Tumor-Infiltrating Lymphocytes (TIL) From People With Non-Small Cell Lung Cancer Following Preparative Chemotherapy
Conditions: Metastatic Non-Small Cell Lung Cancer;   Squamous Cell Carcinoma;   Advanced NSCLC;   Adenosquamous Carcinoma;   Adenocarcinomas
Interventions: Drug: Aldesleukin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Young TIL
13 Recruiting STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
Condition: Small Cell Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide
14 Recruiting Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer
Condition: Stage III Non-small-cell Lung Cancer
Intervention: Radiation: Radiotherapy
15 Recruiting Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
Conditions: Non-small Cell Lung Cancer;   Effects of Chemotherapy
Interventions: Drug: Gefitinib group;   Drug: Vinorelbine, Ifosfamide, Mesna
16 Recruiting Immunotherapy With Racotumomab in Advanced Lung Cancer
Conditions: NSCLC;   Lung Cancer, Non-small Cell
Interventions: Biological: Racotumomab;   Other: Best Support Treatment
17 Not yet recruiting Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Dietary Supplement: soy isoflavones;   Drug: cisplatin;   Drug: etoposide;   Drug: pemetrexed disodium;   Radiation: radiation therapy
18 Recruiting A Phase II Study of Chemotherapy Regimen Plus Bevacizumab in Elderly Non-small Cell Lung Cancer (NSCLC) Patients Selected by Geriatric Assessment
Condition: Non-small Cell Lung Cancer (NSCLC)
Intervention: Biological: bevacizumab, carboplatin and paclitaxel
19 Recruiting Feasibility of Mutational Analysis of Non-Small Cell Lung Cancer (NSCLC) Using Low-volume Lung Aspirates
Condition: Lung Cancer
Intervention: Procedure: biopsy
20 Unknown  Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: paclitaxel;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years